Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Published January 2009 | Forecasts through 2015
Global Neurosurgical Product Markets
Reports Graph
Overview
Common conditions necessitating the use of neurosurgical products include hydrocephalus, aneurysms, arteriovenous malformations (AVMs), and pituitary and intracranial tumors. Intracranial shunts are often used to treat hydrocephalus. Aneurysms and AVMs may be treated using surgical clips or, increasingly, embolization products that may be deployed during endovascular procedures. Pituitary and intracranial tumors may be removed during open surgery, endoscopic surgery, or stereotactic radiosurgery (SRS).

The market for minimally invasive (MI) neurosurgical technologies for intracranial applications is expected to reach $3.7 billion by 2015. This in-depth report analyzes the trends and opportunities in the global neurosurgical products market and provides details on the current and future outlook for the patient populations, procedures, and competitors driving growth and innovation.
Buy Global Neurosurgical Product Markets
Companies Covered
Accuray
Aesculap (B. Braun)
American Radiosurgery
Boston Scientific
BrainLAB
Cardinal Health
Clarus Medical Systems
Codman & Shurtleff (Johnson & Johnson)
Cordis (Johnson & Johnson)
Elekta
ev3
GammaStar Group
Hitachi
Integra LifeSciences
Ion Beam Applications
Johnson & Johnson
KARL STORZ Endoscopy
Kirwan Surgical Products
Machida Endoscope
Medicon
Medtronic
Micro Therapeutics/EV3
Microvention/Terumo
Micrus Endovascular
Mizuho America
Nfocus Neuromedical
Olympus
Optivus Proton Therapy
Peter Lazic
Rebstock-Instrumente
Scanlan International
Siemens
Sophysa
Still River Systems
TomoTherapy
Varian Medical Systems
Visionsense
Von Zeppelin
VYGON Neuro
Zeppelin Medical Instruments

Order individually or subscribe and
get a complete intel platform.

Trusted By The Companies Pioneering What’s Next